James Wassil
Geschäftsführer bei VAXCYTE, INC.
Vermögen: 15 Mio $ am 31.05.2024
Aktive Positionen von James Wassil
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
VAXCYTE, INC. | Geschäftsführer | 01.12.2019 | - |
Karriereverlauf von James Wassil
Ehemalige bekannte Positionen von James Wassil
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ICOSAVAX, INC. | Direktor/Vorstandsmitglied | 01.06.2022 | 19.02.2024 |
Independent Dir/Board Member | 01.06.2022 | 19.02.2024 | |
PFIZER, INC. | Corporate Officer/Principal | 01.05.2015 | 01.12.2019 |
NOVARTIS AG | Corporate Officer/Principal | 01.08.2008 | 01.05.2015 |
Infectious Diseases Society of America
Infectious Diseases Society of America Miscellaneous Commercial ServicesCommercial Services The Infectious Diseases Society of America is a non-profit company that provides clinical practice guidelines development and guideline panelists for infectious diseases. The company is based in Arlington, VA and has subsidiaries in the United States. The company specializes in antimicrobial stewardship and have established Antimicrobial Stewardship Centers of Excellence. The CEO of the company is Christopher Busky. | Corporate Officer/Principal | - | - |
MERCK & CO., INC. | Vertrieb & Marketing | - | - |
Ausbildung von James Wassil
University of Notre Dame | Undergraduate Degree |
Lehigh University | Graduate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Schweiz | 2 |
Operativ
Corporate Officer/Principal | 3 |
Chief Operating Officer | 1 |
Sales & Marketing | 1 |
Sektoral
Health Technology | 6 |
Consumer Services | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
VAXCYTE, INC. | Health Technology |
PFIZER, INC. | Health Technology |
NOVARTIS AG | Health Technology |
MERCK & CO., INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Infectious Diseases Society of America
Infectious Diseases Society of America Miscellaneous Commercial ServicesCommercial Services The Infectious Diseases Society of America is a non-profit company that provides clinical practice guidelines development and guideline panelists for infectious diseases. The company is based in Arlington, VA and has subsidiaries in the United States. The company specializes in antimicrobial stewardship and have established Antimicrobial Stewardship Centers of Excellence. The CEO of the company is Christopher Busky. | Commercial Services |
Icosavax, Inc.
Icosavax, Inc. Pharmaceuticals: MajorHealth Technology Icosavax, Inc. engages in the development and commercialization of vaccines against infectious diseases. It focuses on developing vaccine candidates for viral causes of pneumonia in older adults. The company was founded by Neil King and David Baker on November 1, 2017 and is headquartered in Seattle, WA. | Health Technology |
- Börse
- Insiders
- James Wassil
- Erfahrung